Clinical Trial Update: Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD) [NA]

View source ↗

Summary

This clinical trial update announces the GOLD-STANDARD study evaluating goal-directed therapy to reduce kidney and cardiovascular risk in diabetic kidney diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Diabetic Kidney Disease (DKD) | NA | Status: NOT_YET_RECRUITING